Skip to main content
. 2021 Mar 19;11(3):460. doi: 10.3390/biom11030460

Figure 4.

Figure 4

(A) Co-crystallized ligand (NAG) docked into the active site of COVID-19 spike glycoprotein. (B) Mapping surface showing co-crystallized ligand (NAG) occupying the active pocket of COVID-19 spike glycoproteins.